Next Article in Journal
A Comprehensive Identification and Expression Analysis of VQ Motif-Containing Proteins in Sugarcane (Saccharum spontaneum L.) under Phytohormone Treatment and Cold Stress
Next Article in Special Issue
New 3,4-seco-3,19-Dinor- and Spongian-Based Diterpenoid Lactones from the Marine Sponge Spongia sp.
Previous Article in Journal
Analysis of Nanomaterials on Biological and Environmental Systems and New Analytical Methods for Improved Detection
Previous Article in Special Issue
Verrucosidin Derivatives from the Deep Sea Cold-Seep-Derived Fungus Penicillium polonicum CS-252
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Uncommon Polyketides from Penicillium steckii AS-324, a Marine Endozoic Fungus Isolated from Deep-Sea Coral in the Magellan Seamount

1
CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Nanhai Road 7, Qingdao 266071, China
2
Laboratory of Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Wenhai Road 1, Qingdao 266237, China
3
College of Marine Science, University of Chinese Academy of Sciences, Yuquan Road 19A, Beijing 100049, China
4
Center for Ocean Mega-Science, Chinese Academy of Sciences, Nanhai Road 7, Qingdao 266071, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(11), 6332; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23116332
Submission received: 30 April 2022 / Revised: 28 May 2022 / Accepted: 28 May 2022 / Published: 6 June 2022

Abstract

:
Four unusual steckwaic acids E–H (14), possessing a rarely described acrylic acid unit at C-4 (13) or a double bond between C-12 and C-13 (4) are reported for the first time, along with four new analogues (58) and two known congeners (9 and 10). They were purified from the organic extract of Penicillium steckii AS-324, an endozoic fungus obtained from a deep-sea coral Acanthogorgiidae sp., which was collected from the Magellan Seamount at a depth of 1458 m. Their structures were determined by the interpretation of NMR and mass spectroscopic data. The relative and absolute configurations were determined by NOESY correlations, X-ray crystallographic analysis, and ECD calculations. All compounds were tested for their antimicrobial activities against human- and aquatic-pathogenic bacteria and plant-related pathogenic fungi.

1. Introduction

Deep-sea-living organisms have evolved under extreme environmental conditions, which have influenced the development of various biochemical functions compared to those living in shallow-water organisms [1,2]. Although the area of deep-sea habitats is much larger than that of shallow-sea habitats, compounds isolated from deep-sea organisms accounted for only ~2% of the more than 30,000 marine natural products [3,4], whereas approximately 75% of these molecules exhibited notable bioactivities. Improved technological capacity for sampling from the deep-sea environment has improved the discovery of deep-sea-derived natural products. In recent years, the number of deep-sea-sourced natural products increased rapidly, and these compounds usually display high bioactivity hits in bioassays [5]. Although the nature of the associations between a host and its associated microbes is far from understood, there is growing evidence that some coral-associated fungi have adopted the ability to produce secondary metabolites that are structurally divergent from their terrestrial counterparts [6,7,8]. Marine animal-related fungi often produce bioactive metabolites that might be interpreted as chemically mediated defense mechanisms to protect their host organisms from environmental hazards such as predation and pathogenic invasion [9]. Some studies have reported on the isolation of marine coral-associated Penicillium spp. as producers of bioactive metabolites [10,11,12].
Following our ongoing research about secondary metabolites from marine-derived fungi collected from deep-sea habitats [13,14], an endozoic fungus Penicillium steckii AS-324, obtained from the fresh tissues of deep-sea coral Acanthogorgiidae sp. collected from Magellan seamount in the Western Pacific Ocean at a depth of 1458 m, was cultured and chemically investigated. P. steckii has recently been proved to be an excellent source of antibacterial compounds based on genome sequencing and mining, as well as antibacterial screening of the crude extracts [15]. Eight new tanzawaic acid derivatives (18), together with two known analogues, tanzawaic acid H (9) [16] and tanzawaic acid S (10) [17], were isolated and identified. We recently reported 10 new tanzawaic acid derivatives, including steckwaic acids A–D from P. steckii AS-324 [18]. Further work on the remaining portions of this fungus resulted in the characterization of eight new (18) and two known (9 and 10) tanzawaic acid analogues (Figure 1). Among these compounds, steckwaic acids E–G (13) possess a rarely described acrylic acid unit at C-4, while compound 4 has a double bond at C-12, which is uncommon among the reported tanzawaic acids [16,17,18]. Details of the isolation, structure elucidation, and antimicrobial activity of compounds 110 are described herein.

2. Results

The culture of P. steckii AS-324 was extracted with EtOAc to gain the organic extract, which was then fractionated and purified by various chromatographic methods to yield compounds 110 (Figure 1).
Steckwaic acid E (1) was initially obtained as a white amorphous powder, and the molecular formula was assigned as C16H24O3 by negative HRESIMS data. The 1H and 13C NMR data (Table 1) revealed the presence of three doublet methyl substitutions, one methylene, eleven methines (with one oxygenated and four olefinic), and one carboxyl carbon. A large spin system incorporating H-2 through H-13 and three methyls, H3-14, H3-15, and H3-16, confirmed the presence of a decalin skeleton with three methyl-substitution at C-6, C-8, and C-13 (Figure 2). HMBC correlations from H-3 to C-1, C-5, and C-13 and from H-2 to C-4 indicated the position of one acrylic acid side chain at C-4 (Figure 2). The large coupling constant between H-2 and H-3 (J = 15.4 Hz) suggested the E-geometry of the double bond, whereas the smaller coupling constant between H-11 and H-12 (J = 9.8 Hz) revealed the Z-geometry. Thus, the planar structure of 1 was determined. The coupling constants between H-4 and H-5, between H-5 and H-10, and between H-8 and H-9, as well as between H-9 and H-10, were all 9.5 Hz, indicating the trans-orientation of these adjacent proton pairs in the cyclohexane/cyclohexene units. NOESY correlations from H-3 to H-5 and H3-15, as well as from H-5 to H-9, demonstrated them on the same face of these protons, while correlations from H-10 to H-6, H-8, and H-13 placed them on the opposite side (Figure 3).
To unambiguously confirm the structure and configuration of compound 1, attempts to cultivate quality crystals were performed, and suitable crystals were obtained by dissolving the samples in MeOH and refrigerating them to evaporate the solvent slowly. Single-crystal X-ray diffraction analysis using Cu Kα radiation confirmed the structure of 1, and the absolute configuration was 4S, 5R, 6R, 8S, 9R, 10R, and 13S with the Flack parameter −0.09(13) (Figure 4).
Steckwaic acid F (2), obtained as colorless crystals, was assigned a molecular formula of C16H22O4 according to the HRESIMS analysis. Detailed inspection of its NMR data revealed the same skeleton as that of compound 1, and the main differences are that the oxygenated methine resonating at δC/δH 77.0/2.59 (CH-9) in 1 was replaced by methylene resonating at δC/δH 35.4/1.93 and 1.11 (CH2-9) in 2, whereas a carboxyl carbon resonating at δC 176.9 (C-16) was observed by HMBC in 2, which replaced the methyl group resonating at δC/δH 19.2/0.91 (CH3-16) in 1. The large spin system similar to that in 1 was otherwise intact, albeit with some chemical shift differences and the absence of the methyl group CH3-16 in 2 (Figure 2). HMBC correlations from H-8 and H-9 to the carboxyl carbon C-16, as well as from H-9 to C-5 and C-7, confirmed the planar structure of compound 2 (Figure 2). The coupling constant between H-2 and H-3 (J = 15.3 Hz) suggested the E-geometry of the double bond. NOE correlations from H-3 to H-5, H3-14, and H3-15 suggested the protons were in the same orientation, whereas correlations from H-6 to H-4 and H-8 as well as from H-8 to H-10 positioned them on the other side (Figure 3). The structure and absolute configuration of compound 2 were confirmed by X-ray diffraction analysis using Cu Kα radiation, and the Flack parameter 0.05(10) permitted assignment of the absolute configuration as 4S, 5S, 6R, 8S, 10R, and 13S (Figure 4).
Steckwaic acid G (3), obtained as a white amorphous powder, was assigned the molecular formula C16H24O3 by HRESIMS and NMR data. The chemical structure of compound 3 was almost identical to that of 2. The main difference between 3 and 2 was evident in the nonappearance of one of the two carboxyl carbons C-16 (δC 176.9 in 2) in the 13C-NMR spectrum of 3, the appearance of 1H- and 13C-NMR resonances for an oxymethylene moiety CH2-16 (δC 66.3 and δH 3.20 in 3), and the related changes in chemical shifts and multiplicities of nearby carbons and protons around CH-9 (Table 1). This spectral evidence suggests that the carboxyl carbon C-16 in 2 was reduced to form an oxymethylene unit in 3, and this assignment was further confirmed by COSY and HMBC correlations (Figure 2). The coupling constant between H-2 and H-3 (J = 15.4 Hz) was similar to that observed in compound 2, which indicated the E-geometry of the double bond at C-2. NOESY correlations from H-3 to H-5, H3-14, and H3-15 supported the cofacial orientation of these protons, while correlations from H-6 to H-4 and H-8, as well as from H-10 to H-8 and H-13, placed these groups on the opposite face (Figure 3). The ECD spectrum of 3 closely matched that of 1 and 2, which showed the same positive cotton effects near 225 nm (Figure 5), enabling the assignment of the absolute configurations of compound 3 as 4S, 5S, 6R, 8S, 10R, and 13S.
Steckwaic acid H (4) was determined to have the molecular formula C18H26O3 based on the negative HRESIMS data. Its NMR data (Table 2) displayed typical signals of a decalin skeleton with three methyl signals for C-8, C-10, and C-15, and the appropriately modified acrylic acid substituent in 13 was changed to a penta-2,4-dienoic acid moiety in 4. HMBC correlations from the olefinic proton H-13 to C-7, C-11, and C-15, as well as from H-6 and H-14 to the nonprotonated olefinic carbon C-12, were located in the position of a double bond between C-12 and C-13. In addition, HMBC correlations from the oxymethine proton H-14 to C-6, C-12, and C-18 confirmed the hydroxy-substituent at C-14. Large coupling constants between H-2 and H-3 (J = 15.3 Hz), as well as H-4 and H-5 (J = 15.1 Hz), showed the E-geometry of two double bonds at C-2 and C-4. The relative configuration of 4 was determined by a NOESY spectrum. NOE correlations from H-5 to H-7, H-14, H3-16, and H3-17 placed them on the same face of the molecule, whereas correlations from H-8 to H-10 indicated these protons were on the other side. To clarify the absolute configuration of 4, the ECD spectra of minimum energy conformers by the TDDFT method at BH&HLYP/TZVP and CAM-B3LYP/TZVP levels were calculated, and the experimental ECD spectrum of 4 matched well with that of the calculated spectrum for (6R, 7R, 8R, 10S, 14S, and 15R)-4 (Figure 6 and Figure S59).
Compound 5 was obtained as a white amorphous powder, and the molecular formula was assigned as C19H28O4 by HRESIMS data. Detailed analysis of the 1H and 13C data (Table 2) showed that it was similar to tanzawaic acid U [17] except that resonances for the methine unit at δC 32.3 and δH 1.46 (CH-10) in tanzawaic acid U were replaced by an oxygenated/nonprotonated carbon at δC 68.0 (C-10) in 5. These observations were further supported by relevant COSY and HMBC correlations (Figure 2). The coupling constants of two double bonds at C-2 and C-4 were 15.2 and 15.3 Hz, respectively, suggesting E-geometry for the double bonds. NOE correlations from H-5 to H-7 and H3-17, as well as from H3-17 to H3-18, indicated the same orientation of these protons, while correlations from H-6 to H-12 and H-13 showed them on the opposite side. The absolute configuration of 5 was determined by both ECD calculation and comparisons with known compounds 9 and 10. The experimental ECD spectrum of 5 aptly matched the calculated spectra of (6R, 7R, 8R, 10R, 12S, 13S)-5 at BH&HLYP/TZVP, CAM-B3LYP/TZVP, and PBE0/TZVP levels (Figure 7 and Figure S59). Besides, 5 showed a positive Cotton effect at approximately 264 nm similar to that of compounds 9 and 10 (Figure 8), which also confirmed the absolute configuration of 5. Compound 5 was named 10-hydroxytanzawaic acid U.
Compound 6 was isolated as a white amorphous powder and assigned the molecular formula C20H28O5 by negative HRESIMS data. A detailed comparison of the NMR spectral data (Table 2) with the known compound tanzawaic acid R [17] suggested that they were very similar. However, signals for a carboxyl carbon at δC 170.4 and a methyl group at δC/δH 20.7/2.00 related to an acetoxyl group were observed in the NMR spectra of 6. HMBC correlations from H2-18 to C-9, C-11, and C-19 as well as H3-20 to C-19 placed the acetoxyl group at C-18 (Figure 2). Large coupling constants between H-2 and H-3, as well as between H-4 and H-5 (J = 15.3 Hz), indicated the E-geometry of two double bonds. NOESY correlations from H3-17 to H-5, H-7, and H2-18, as well as from H2-18 to H-11β, suggested the same orientation of these protons, while correlations from H-12 to H-8 and H-10 as well as from H-13 to H-11α placed these groups on the opposite face. From the ECD data and biogenetic considerations, the absolute configuration of compound 6 was assigned as 6R, 7R, 8R, 10S, 12S, and 13S. Compound 6 was named 18-O-acetyltanzawaic acid R.
Steckwaic acid I (7) was obtained as a white amorphous powder, and the molecular formula was assigned as C19H28O4 by analysis of the HRESIMS data. A detailed comparison of the NMR spectral data between 7 (Table 3) and tanzawaic acid S (10) [17] suggested that they were very similar, except the coupling constant between H-4 and H-5 (J = 11.1 Hz) in 7 was much smaller than that of 10 (J4,5 = 15.3 Hz), indicating the geometry of the double bond at C-4 changed from E in 10 to Z in 7. The planar structure was further determined by COSY and HMBC correlations (Figure 2), and the relative configuration was confirmed by the NOESY spectrum. The NOESY correlations from H-5 to H-7 and H3-17 showed these groups to be on the same side, whereas correlations from H-6 to H-8, H-12, and H-13, as well as from H-10 to H-8 and H-12, indicated the opposite side of these protons. The absolute configuration of 7 was confirmed by comparing the ECD spectrum with those of known compounds 9 and 10. The same positive Cotton effects around 265 nm demonstrated consistent absolute configurations with those of 6R, 7R, 8R, 10S, 12S, and 13S.
Compound 8 was also obtained as a white amorphous powder with the molecular formula C19H28O4 as measured by HRESIMS. Analysis of 1H and 13C NMR data (Table 3) showed similarities to those reported for tanzawaic acid S (10) that were measured in methanol-d4 [17] and our isolates that were measured in DMSO-d6 (Experimental section). The primary differences between 8 and 10 were the signals of an oxygenated methine at δC/δH 80.3/3.32 (CH-13) in 8 replaced by signals at δC/δH 75.3/3.37 (CH-13) in 10, revealing the configuration at C-13 had been changed. This deduction was further supported by the relevant COSY and HMBC correlations shown in Figure 2, as well as NOESY data shown in Figure 3. NOE correlations from H-5 to H-7 and H3-17, from H-7 to H-13, and from H2-18 to H-11β suggested they were on one side, whereas correlations from H-6 to H-8 and H-12 and from H-13-OCH3 to H-10 and H-11α placed them on another face. By comparing the ECD spectrum with that of compounds 9 and 10, the absolute configuration of 8 was assigned as 6R, 7R, 8R, 10S, 12S, and 13R. Compound 8 was named 13R-tanzawaic acid S.
In addition to the new compounds 18, two structurally related known analogues 9 and 10 were also isolated, and their structures were identified as tanzawaic acid H (9) and tanzawaic acid S (10) based on the comparison of NMR data, optical rotations, and ECD spectra with those described in literature reports [16,17].
The absolute configurations of major chiral centers for compounds 110 are consistent except for position C-13. In comparison to 13S methoxy-substituent (compounds 5, 7, and 10), the resonance of C-13 in the 13R isomer (compound 8) shifted ~5 ppm downfield in the 13C NMR spectra. An analogous carbon (4.4 ppm) was observed for the analogous hydroxy-substituent when comparing compound 6 with compound 9. Besides, for the compounds with the same absolute configuration at C-13 (5, 6, 7, and 10), the methoxy-substituent (5, 7, and 10) could shift downfield approximately 10 ppm in the 13C NMR spectra compared to that of hydroxy-substituent (6).
Although some tanzawaic acid derivatives were tested for their cytotoxic [16] and lipid-lowering [17] activities, a few of them exhibited significant activities. Compounds 110 were assayed for their antibacterial activities against one human and nine aquatic pathogenic bacteria as well as seven plant-pathogenic fungi. Compound 8 showed moderate activity against the human pathogenic bacterium Escherichia coli with an MIC value of 8 μg/mL (the MIC value of the positive control chloramphenicol was 1 μg/mL), while compound 10 exhibited inhibitory activity against the aquatic pathogenic bacterium Edwardsiella tarda with an MIC value of 16 μg/mL (the MIC value of the positive control chloramphenicol was 2 μg/mL) (Table 4). The results suggested that the absolute configuration of C-13 influenced the antibacterial activities of different bacteria (8 vs. 10) as supported by the fact that compound 8 with a 13R configuration showed stronger activity against E. coli but weaker activity against E. tarda, while compound 10 with a 10S configuration showed stronger activity against E. tarda but no activity against E. coli. The geometry of the double bond at C-4 also affected the activity (7 vs. 10), revealed by the fact that the E-geometry (10) exhibited stronger activity against E. tarda while compound 7 with Z-geometry at C-4 did not show any activity. Other compounds did not exhibit antimicrobial activities (MIC > 64 μg/mL).

3. Materials and Methods

3.1. General Experimental Procedures

General experimental procedures were the same as previously reported [19,20].

3.2. Fungal Material

The fungal strain Penicillium steckii AS-324 was obtained from fresh tissues of Acanthogorgiidae sp., which were collected from Magellan seamount. Taxonomic identification of the fungus was accomplished by comparing its ITS region sequence to that of Penicillium steckii (MT582790.1), which showed 99.64% similarity. The sequence data of the fungus AS-324 were submitted and deposited in GenBank with the accession no. OK605032. The fungal strain is preserved at the Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences (IOCAS, Qingdao, China).

3.3. Fermentation, Extraction, and Isolation

For chemical investigations, the fresh mycelia of P. steckii AS-324 were grown on PDA medium at 28 °C for five days and were then inoculated into 125 × 1 L Erlenmeyer flasks with rice solid medium (70 g rice, 0.1 g corn syrup, 0.3 g peptone, 0.1 g methionine, and 100 mL naturally sourced and filtered seawater that was obtained from the Huiquan Gulf of the Yellow Sea near the campus of IOCAS), and statically cultured for 30 days at room temperature. After incubation, the fermented rice substrate was extracted three times with EtOAc. The combined EtOAc extracts were filtered and evaporated under reduced pressure to yield organic extract (120 g), which was subjected to vacuum liquid chromatography (VLC) eluting with different solvents of increasing polarity from petroleum ether (PE) to MeOH to yield nine fractions (Frs. 1–9). Fr. 6 (11 g), eluted with PE–EtOAc (1:1), was purified by column chromatography (CC) over Lobar LiChroprep RP-18 with a MeOH-H2O gradient (from 10:90 to 100:0) to afford seven subfractions (Frs. 6.1–6.7). Fr. 6.4 (eluted with MeOH-H2O, 40:60, 260 mg) was further purified by CC on Si gel eluting with a CH2Cl2-MeOH gradient (from 100:1 to 20:1) to gain Frs. 6.4.1−6.4.3. Fr. 6.4.1 was further purified by prep. TLC (plate: 20 × 20 cm, developing solvents: PE-Acetone, 1:1) and Sephadex LH-20 (MeOH) to obtain compound 1 (42.3 mg). Fr. 6.4.2 was further purified by semi-preparative HPLC (Elite ODS-BP column, 10 μm; 20 × 250 mm; 50% MeOH-H2O, 10 mL/min) to gain compounds 2 (15.6 mg, tR = 15.5 min) and 4 (22.8 mg, tR = 17.5 min). Fr. 6.4.3 was purified by prep. TLC (plate: 20 × 20 cm, developing solvents: CH2Cl2-Acetone, 3:1) and Sephadex LH-20 (MeOH) to obtain compound 3 (10.2 mg). Fr. 7 (5.5 g), eluted with CH2Cl2-MeOH (20:1), was purified by reverse-phase column chromatography (CC) over Lobar LiChroprep RP-18 with a MeOH-H2O gradient (from 10:90 to 100:0) to yield five subfractions (Frs. 7.1–7.5). Fr. 7.3 (eluted with MeOH-H2O, 50:50, 326 mg) was further purified by CC on Si gel eluting with a CH2Cl2-MeOH gradient (from 100:1 to 20:1), prep. TLC (plate: 20 × 20 cm, developing solvents: PE-Acetone, 1:1), and Sephadex LH-20 (MeOH) to obtain compounds 5 (3.0 mg) and 10 (38.7 mg). Fr. 7.4 (eluted with MeOH-H2O, 60:40, 118 mg) was fractionated by CC on Si gel eluting with a CH2Cl2-MeOH gradient (from 80:1 to 20:1) and Sephadex LH-20 (MeOH) to afford compound 6 (20.4 mg). Fr. 8 (10.0 g), eluted with CH2Cl2/MeOH (10:1), was purified by reverse-phase CC over Lobar LiChroprep RP-18 with an MeOH-H2O gradient (from 10:90 to 100:0) to yield three subfractions (Frs. 8.1–8.3). Fr. 8.1 (eluted with MeOH–H2O 30:70) was further purified by CC on Si gel eluting with a CH2Cl2-MeOH gradient (from 100:1 to 50:1) and semi-preparative HPLC (Elite ODS-BP column, 10 μm; 20 × 250 mm; 60% MeOH-H2O, 10 mL/min) to gain compounds 7 (13.2 mg, tR = 18.7 min) and 9 (8.9 mg, tR = 16.5 min). Fr. 8.3 (eluted with MeOH-H2O 50:50) was further purified by CC on Si gel eluting with a CH2Cl2-MeOH gradient (from 100:1 to 50:1), prep. TLC (plate: 20 × 20 cm, developing solvents: PE-Acetone, 1:1), semi-preparative HPLC (Elite ODS-BP column, 10 μm; 20 × 250 mm; 45% MeOH-H2O, 10 mL/min), and Sephadex LH-20 (MeOH) to obtain compound 8 (3.0 mg).
Steckwaic acid E(1): Colorless crystals (MeOH); mp 178–180 °C; [ α ] D 25 +56.0 (c 0.25, MeOH); UV (MeOH) λmax (log ε) 217 (3.19) nm; ECD (0.95 mM, MeOH) λmaxε) 225 (+5.42) nm; 1H and 13C NMR data, Table 1; ESIMS m/z 263 [M − H]; HRESIMS m/z 263.1657 [M − H] (calcd for C16H23O3, 263.1653).
Steckwaic acid F(2): Colorless crystals; mp 242–244 °C; [ α ] D 25 +30.8 (c 0.26, MeOH); UV (MeOH) λmax (log ε) 216 (3.12) nm; ECD (0.72 mM, MeOH) λmaxε) 223 (+4.17) nm; 1H and 13C NMR data, Table 1; ESIMS m/z 277 [M − H]; HRESIMS m/z 277.1439 [M − H] (calcd for C16H21O4, 277.1445).
Steckwaic acid G (3): White amorphous powder; [ α ] D 25 +67.9 (c 0.28, MeOH); UV (MeOH) λmax (log ε) 213 (2.95) nm; ECD (0.95 mM, MeOH) λmaxε) 223 (+3.22), 295 (+0.53) nm; 1H and 13C NMR data, Table 1; ESIMS m/z 263 [M − H]; HRESIMS m/z 263.1657 [M − H] (calcd for C16H23O3, 263.1653).
Steckwaic acid H(4): Colorless oil; [ α ] D 25 −34.5 (c 0.29, MeOH); UV (MeOH) λmax (log ε) 260 (3.00) nm; ECD (0.34 mM, MeOH) λmaxε) 220 (+0.19), 295 (+0.16) nm; 1H and 13C NMR data, Table 2; ESIMS m/z 289 [M − H]; HRESIMS m/z 289.1809 [M − H] (calcd for C18H25O3, 289.1809).
10-Hydroxytanzawaic acid U (5): White amorphous powder; [ α ] D 25 +50.0 (c 0.10, MeOH); UV (MeOH) λmax (log ε) 265 (3.08) nm; ECD (1.56 mM, MeOH) λmaxε) 264 (+6.12) nm; 1H and 13C NMR data, Table 2; ESIMS m/z 319 [M − H]; HRESIMS m/z 319.1908 [M − H] (calcd for C19H27O4, 319.1915).
18-O-Acetyltanzawaic acid R (6): White amorphous powder; [ α ] D 25 +82.5 (c 0.40, MeOH); UV (MeOH) λmax (log ε) 265 (3.32) nm; ECD (0.72 mM, MeOH) λmaxε) 261 (+12.0) nm; 1H and 13C NMR data, Table 2; ESIMS m/z 347 [M − H]; HRESIMS m/z 347.1861 [M − H] (calcd for C20H27O5, 347.1864).
Steckwaic acid I(7): White amorphous powder, [ α ] D 25 +165.2 (c 0.23, MeOH); UV (MeOH) λmax (log ε) 263 (3.27) nm; ECD (0.78 mM, MeOH) λmaxε) 262 (+12.2) nm; 1H and 13C NMR data, Table 3; ESIMS m/z 319 [M − H]; HRESIMS m/z 319.1908 [M − H] (calcd for C19H27O4, 319.1915).
13R-Tanzawaic acid S (8): Colorless solid; [ α ] D 25 +254.5 (c 0.22, MeOH); UV (MeOH) λmax (log ε) 265 (3.50) nm; ECD (0.78 mM, MeOH) λmaxε) 266 (+17.4) nm; 1H and 13C NMR data, Table 3; ESIMS m/z 319 [M − H]; HRESIMS m/z 319.1912 [M − H] (calcd for C19H27O4, 319.1915).
Tanzawaic acid S (10): Colorless solid; [ α ] D 25 +76.9 (c 0.13, MeOH); UV (MeOH) λmax (log ε) 264 (3.39) nm; ECD (0.86 mM, MeOH) λmaxε) 263 (+14.7) nm; 1H NMR data (DMSO-d6) δH: 5.80 (1H, m, H-2), 7.12 (1H, dd, J = 14.5, 10.9 Hz, H-3), 6.27 (1H, dd, J = 15.3, 10.9 Hz, H-4), 5.93 (2H, m, H-5, H-14), 2.54, (1H, m, H-6), 1.23 (3H, m, H-7, H-10, H-12), 0.63 (1H, m, H-8), 1.59 (2H, m, H-9a, H-11a), 1.45 (1H, m H-9b), 1.08 (1H, m, H-11b), 3.37 (1H, dd, J = 6.1, 1.8 Hz, H-13), 1.57, (3H, s, H3-16), 0.87 (3H, d, J = 6.5 Hz, H3-17), 3.19 (2H, d, J = 6.2 Hz, H2-18), 3.22 (3H, s, H3-13-OCH3); 13C NMR data (DMSO-d6) δC: 170.0 (C, C-1), 120.8 (CH, C-2), 143.7 (CH, C-3), 129.2 (CH, C-4), 148.4 (CH, C-5), 49.5 (CH, C-6), 44.2 (CH, C-7), 39.2 (CH, C-8), 39.5 (CH2, C-9), 40.0 (CH, C-10), 32.7 (CH2, C-11), 42.1 (CH, C-12), 75.3 (CH, C-13), 124.0 (CH, C-14), 139.1 (C, C-15), 22.0 (CH3, C-16), 21.9 (CH3, C-17), 66.6, (CH2, C-18), 55.8 (CH3, C-13-OCH3); ESIMS m/z 319 [M − H]; HRESIMS m/z 319.1914 [M − H] (calcd for C19H27O4, 319.1915).

3.4. X-ray Crystallographic Analysis of Compounds 1 and 2

Colorless crystals of compounds 1 and 2 were obtained from the solution of MeOH. Crystallographic data were collected on a Bruker D8 Venture diffractometer equipped with a graphite-monochromatic Cu Kα radiation (λ = 1.54178) Å at 173 K [21]. The data were corrected for absorption by using the program SADABS [22]. The structures were solved by direct methods with the SHELXTL software package [23,24]. All non-hydrogen atoms were refined anisotropically. The H atoms connected to C atoms were calculated theoretically, and those to O atoms were assigned by difference Fourier maps. The absolute structures were determined by refinement of the Flack parameter [25]. The structures were optimized by full-matrix least-squares techniques.
Crystal data for compound1: C16H24O3, F.W. = 264.35, monoclinic space group P2(1), unit cell dimensions a = 5.7450(10) Å, b = 12.778(3) Å, c = 10.226(3) Å, V = 749.3(3) Å3, α = γ = 90°, β = 93.424(14), Z = 2, dcalcd = 1.172 mg/m3, crystal dimensions 0.200 × 0.180 × 0.160 mm, μ = 0.632 mm−1, F(000) = 288. The 2734 measurements yielded 2464 independent reflections after equivalent data were averaged. The final refinement gave R1 = 0.0421 and wR2 = 0.1125 [I > 2σ(I)]. The absolute structure parameter was −0.09(13).
Crystal data for compound2: C16H22O4, F.W. = 278.33, orthorhombic space group P2(1)2(1)2(1), unit cell dimensions a = 5.18970(10) Å, b = 11.7476(2) Å, c = 24.0950(5) Å, V = 1468.99(5) Å3, α = β = γ = 90°, Z = 4, dcalcd = 1.259 mg/m3, crystal dimensions 0.180 × 0.160 × 0.140 mm, μ = 0.727 mm−1, F(000) = 600. The 2681 measurements yielded 2409 independent reflections after equivalent data were averaged. The final refinement gave R1 = 0.0371 and wR2 = 0.0956 [I > 2σ(I)]. The absolute structure parameter was 0.05(10).

3.5. Computational Section

Conformational searches were performed via molecular mechanics using the MMFF method in Macromodel software, and the geometries were reoptimized at the B3LYP/6-31G(d) PCM/MeOH level using Gaussian 09 software to obtain the energy-minimized conformers [26]. Then, the optimized conformers were subjected to calculate the ECD spectra using TDDFT at the BH&HLYP/TZVP, CAM-B3LYP/TZVP, and PBE0/TZVP levels. The solvent effects of the MeOH solution were evaluated at the same DFT level using the SCRF/PCM method.

3.6. Antimicrobial Assays

The antimicrobial activities against one human pathogenic bacterium (Escherichia coli EMBLC-1), nine aquatic pathogens (Aeromonas hydrophilia QDIO-1, E. tarda QDIO-2, Micrococcus luteus QDIO-3, Pseudomonas aeruginosa QDIO-4, Vibro alginolyticus QDIO-5, V. anguillarum QDIO-6, V. harveyi QDIO-7, V. parahaemolyticus QDIO-8, and V. vulnificus QDIO-10), as well as seven plant-pathogenic fungi (Alternaria solani QDAU-1, Colletotrichum gloeosporioides QDAU-2, Fusarium graminearum QDAU-4, F. oxysporum QDAU-8, Gaeumannomyces graminis QDAU-21, Rhizoctonia cerealis QDAU-20, and Valsa mali QDAU-16), were determined by a serial dilution technique using 96-well microtiter plates [27]. The aquatic pathogenic strains and human pathogenic bacteria were obtained from IOCAS. Tested compounds and the positive control (chloramphenicol for bacteria and amphotericin B for fungi) were dissolved in DMSO to produce a stock solution.

4. Conclusions

In conclusion, eight new polyketide derivatives (18) and two related known analogues (9 and 10) were identified from the endozoic fungus P. steckii AS-324, which was obtained from the fresh tissues of deep-sea Acanthogorgiidae sp. coral collected from Magellan seamount in the Western Pacific Ocean at a depth of 1458 m. Compounds 13, with an acrylic acid side chain at C-4, have been rarely observed [28], and the double bond between C-12 and C-13 in compound 4 is a new observation. Antimicrobial activities of compounds 110 were tested, and compound 8 showed potent activity against E. coli with an MIC value of 8 μg/mL while compound 10 exhibited inhibitory activity against E. tarda with an MIC value of 16 μg/mL.

Supplementary Materials

The following supporting information can be downloaded at: https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/ijms23116332/s1.

Author Contributions

Conceptualization, X.-Y.H., L.-H.M. and B.-G.W.; NMR data collection, X.-M.L.; experiment and analysis, X.-Y.H.; writing—original draft preparation, X.-Y.H.; writing—review and editing, L.-H.M. and B.-G.W.; funding acquisition and project administration, B.-G.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (U2006203 and 41976090), the Natural Science Foundation of Jiangsu province (BK20201211), and the Senior User Project of RV KEXUE (KEXUE2020GZ02).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

B.-G.W. acknowledges the support of the RV KEXUE of the National Major Science and Technology Infrastructure from the Chinese Academy of Sciences (for sampling) and the Oceanographic Data Center at IOCAS (for CPU time).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rothschild, L.J.; Mancinelli, R.L. Life in extreme environments. Nature 2001, 409, 1092–1101. [Google Scholar] [CrossRef] [PubMed]
  2. Wright, P.C.; Westacott, R.E.; Burja, A.M. Piezotolerance as a metabolic engineering tool for the biosynthesis of natural products. Biomol. Eng. 2003, 20, 325–331. [Google Scholar] [CrossRef]
  3. Sun, C.; Mudassir, S.; Zhang, Z.; Feng, Y.; Chang, Y.; Che, Q.; Gu, Q.; Zhu, T.; Zhang, G.; Li, D. Secondary metabolites from deep-sea derived microorganisms. Curr. Med. Chem. 2020, 27, 6244–6273. [Google Scholar] [CrossRef]
  4. Skropeta, D.; Wei, L. Recent advances in deep-sea natural products. Nat. Prod. Rep. 2014, 31, 999–1025. [Google Scholar] [CrossRef] [PubMed]
  5. Marchese, P.; Young, R.; O’Connell, E.; Afoullouss, S.; Baker, B.J.; Allcock, A.L.; Barry, F.; Murphy, J.M. Deep-sea coral garden invertebrates and their associated fungi are genetic resources for chronic disease drug discovery. Mar. Drugs 2021, 19, 390. [Google Scholar] [CrossRef]
  6. Li, J.; Zhong, M.; Lei, M.; Xiao, S.; Li, Z. Diversity and antibacterial activities of culturable fungi associated with coral Porites pukoensis. World J. Microbiol. Biotechnol. 2014, 30, 2551–2558. [Google Scholar] [CrossRef]
  7. Wei, X.; Feng, C.; Zhang, D.-M.; Li, X.-H.; Zhang, C.-X. New indole diketopiperazine alkaloids from soft coral-associated epiphytic fungus Aspergillus sp. EGF 15-0-3. Chem. Biodivers. 2020, 17, e2000106. [Google Scholar] [CrossRef]
  8. Wang, L.; Huang, Y.; Zhang, L.; Liu, Z.; Liu, W.; Xu, H.; Zhang, Q.; Zhang, H.; Yan, Y.; Liu, Z.; et al. Structures and absolute configurations of phomalones from the coral-associated fungus Parengyodontium album sp. SCSIO 40430. Org. Biomol. Chem. 2021, 19, 6030–6037. [Google Scholar] [CrossRef]
  9. Proksch, P.; Edrada, R.A.; Ebel, R. Drugs from the seas–current status and microbiological implications. Appl. Microbiol. Biotechnol. 2002, 59, 125–134. [Google Scholar]
  10. Bao, J.; Sun, Y.-L.; Zhang, X.-Y.; Han, Z.; Gao, H.-C.; He, F.; Qian, P.-Y.; Qi, S.-H. Antifouling and antibacterial polyketides from marine gorgonian coral-associated fungus Penicillium sp. SCSGAF 0023. J. Antibiot. 2013, 66, 219–223. [Google Scholar] [CrossRef] [Green Version]
  11. Chen, Y.; Mao, W.; Wang, J.; Zhu, W.; Zhao, C.; Li, N.; Wang, C.; Yan, M.; Guo, T.; Liu, X. Preparation and structural elucidation of a glucomannogalactan from marine fungus Penicillium commune. Carbohyd. Polym. 2013, 97, 293–299. [Google Scholar] [CrossRef] [PubMed]
  12. Sun, K.; Chen, Y.; Niu, Q.; Zhu, W.; Wang, B.; Li, P.; Ge, X. An exopolysaccharide isolated from a coral-associated fungus and its sulfated derivative activates macrophages. Int. J. Biol. Macromol. 2016, 82, 387–394. [Google Scholar] [CrossRef] [PubMed]
  13. Meng, L.-H.; Li, X.-M.; Zhang, F.-Z.; Wang, Y.-N.; Wang, B.-G. Talascortenes A−G, highly oxygenated diterpenoid acids from the sea-anemone-derived endozoic fungus Talaromyces scorteus AS-242. J. Nat. Prod. 2020, 83, 2528–2536. [Google Scholar] [CrossRef]
  14. Chi, L.-P.; Li, X.-M.; Wan, Y.-P.; Li, X.; Wang, B.-G. Ophiobolin sesterterpenoids and farnesylated phthalide derivatives from the deep sea cold-seep-derived fungus Aspergillus insuetus SD-512. J. Nat. Prod. 2020, 83, 3652–3660. [Google Scholar] [CrossRef] [PubMed]
  15. Yao, G.; Chen, X.; Zheng, H.; Liao, D.; Yu, Z.; Wang, Z.; Chen, J. Genomic and chemical investigation of bioactive secondary metabolites from a marine-derived fungus Penicillium steckii P2648. Front. Microbiol. 2021, 12, 600991. [Google Scholar] [CrossRef] [PubMed]
  16. EI-Neketi, M.; Ebrahim, W.; Lin, W.; Gredara, S.; Badria, F.; Saad, H.A.; Lai, D.; Proksch, P. Alkaloids and polyketides from Penicillium citrinum, an endophyte isolated from the moroccan plant Ceratonia siliqua. J. Nat. Prod. 2013, 76, 1099–1104. [Google Scholar] [CrossRef]
  17. Yu, G.; Wang, S.; Wang, L.; Che, Q.; Zhu, T.; Zhang, G.; Gu, Q.; Guo, P.; Li, D. Lipid-lowering polyketides from the fungus Penicillium Steckii HDN13-279. Mar. Drugs 2018, 16, 25. [Google Scholar] [CrossRef] [Green Version]
  18. Hu, X.-Y.; Li, X.-M.; Wang, B.-G.; Meng, L.-H. Tanzawaic acid derivatives: Fungal polyketides from the deep-sea coral-derived endozoic Penicillium steckii AS-324. J. Nat. Prod. 2022, 85, 1398–1406. [Google Scholar] [CrossRef]
  19. Cao, J.; Li, X.-M.; Li, X.; Li, H.-L.; Konuklugil, B.; Wang, B.-G. Uncommon N-methoxyindolediketopiperazines from Acrostalagmus luteoalbus, a marine algal isolate of endophytic fungus. Chin. J. Chem. 2021, 39, 2808–2814. [Google Scholar] [CrossRef]
  20. Hu, X.-Y.; Wang, C.-Y.; Li, X.-M.; Yang, S.-Q.; Li, X.; Wang, B.-G.; Si, S.-Y.; Meng, L.-H. Cytochalasin derivatives from the endozoic Curvularia verruculosa CS-129, a fungus isolated from the deep-sea squat lobster Shinkaia crosnieri living in the cold seep environment. J. Nat. Prod. 2021, 84, 3122–3130. [Google Scholar] [CrossRef]
  21. Crystallographic data of compounds 1 and 2 have been deposited in the Cambridge Crystallographic Data Centre as CCDCs 2130113 and 2143070, respectively. Hu Xueyi. Cambridge Crystallographic Data Centre. Available online: http://www.ccdc.cam.ac.uk/datarequest/cif (accessed on 29 April 2022).
  22. Sheldrick, G.M. SADABS, Software for Empirical Absorption Correction; University of Göttingen: Göttingen, Germany, 1996. [Google Scholar]
  23. Sheldrick, G.M. SHELXL, Structure Determination Software Programs; Bruker Analytical X-ray System Inc.: Madison, WI, USA, 1997. [Google Scholar]
  24. Sheldrick, G.M. SHELXL, Program for the Refinement of Crystal Structures; University of Göttingen: Göttingen, Germany, 2014. [Google Scholar]
  25. Parsons, S.; Flack, H.D.; Wagner, T. Use of intensity quotients and differences in absolute structure refinement. Acta Crystallogr. Sect. B Struct. Sci. Cryst. Eng. Mater. 2013, B69, 249–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09, Revision D.01; Gaussian, Inc.: Wallingford, CT, USA, 2013. [Google Scholar]
  27. Pierce, C.G.; Uppuluri, P.; Tristan, A.R.; Wormley, F.L., Jr.; Mowat, E.; Ramage, G.; Lopez-Ribot, J.L. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 2008, 3, 1494–1500. [Google Scholar] [CrossRef] [PubMed]
  28. Chen, C.-M.; Chen, W.-H.; Tao, H.-M.; Yang, B.; Zhou, X.-F.; Luo, X.-W.; Liu, Y.-H. Diversified polyketides and nitrogenous compounds from the mangrove endophytic fungus Penicillium steckii SCSIO 41025. Chin. J. Chem. 2021, 39, 2132–2140. [Google Scholar] [CrossRef]
Figure 1. Structures of compounds 110.
Figure 1. Structures of compounds 110.
Ijms 23 06332 g001
Figure 2. Key COSY (bold lines) and HMBC (arrows) correlations of compounds 18.
Figure 2. Key COSY (bold lines) and HMBC (arrows) correlations of compounds 18.
Ijms 23 06332 g002
Figure 3. Key NOESY correlations of compounds 18.
Figure 3. Key NOESY correlations of compounds 18.
Ijms 23 06332 g003
Figure 4. X-ray crystallographic structures of compounds 1 and 2 (with a thermal ellipsoid probability of 50%).
Figure 4. X-ray crystallographic structures of compounds 1 and 2 (with a thermal ellipsoid probability of 50%).
Ijms 23 06332 g004
Figure 5. ECD spectra of compounds 13.
Figure 5. ECD spectra of compounds 13.
Ijms 23 06332 g005
Figure 6. Experimental and calculated ECD of compound 4.
Figure 6. Experimental and calculated ECD of compound 4.
Ijms 23 06332 g006
Figure 7. Experimental and calculated ECD of compound 5.
Figure 7. Experimental and calculated ECD of compound 5.
Ijms 23 06332 g007
Figure 8. Experimental ECD of compounds 510.
Figure 8. Experimental ECD of compounds 510.
Ijms 23 06332 g008
Table 1. 1H and 13C NMR data of compounds 13 in DMSO-d6.
Table 1. 1H and 13C NMR data of compounds 13 in DMSO-d6.
No.123
δC, TypeδH (J in Hz)δC, TypeδH (J in Hz)δC, TypeδH (J in Hz)
1167.6, C 167.4, C a 167.6, C
2120.5, CH5.71, d (15.4)120.1, CH b5.74, d (15.3)120.5, CH5.71, d (15.4)
3154.2, CH6.84, dd (15.4, 10.9)154.2, CH6.88, dd (15.3, 10.9)153.2, CH6.86, dd (15.4, 10.9)
448.0, CH2.46, ddd (10.9, 9.5, 5.6)47.5, CH2.46, td (10.9, 5.0)47.2, CH2.45, td (10.9, 5.4)
544.9, CH1.00, q (9.5)46.0, CH0.98, m46.3, CH0.88, overlap
635.8, CH2.11, m35.7, CH1.37, m35.4, CH1.32, dddq (10.5, 10.1, 3.2, 6.4)
744.4, CH21.56, dt (13.7, 3.8)
0.83, overlap
40.0, CH21.81, overlap
1.11, overlap
40.5, CH21.66, dq (14.3, 3.2)
0.72, overlap
840.0, CH1.35, overlap43.2, CH2.35, m40.0, CH1.52, m
977.0, CH2.59, t (9.5)35.4, CH21.93, d (12.3)
1.11, overlap
35.8, CH21.77, overlap
0.72, overlap
1049.2, CH1.67, td (9.5, 2.0)41.5, CH1.81, overlap41.6, CH1.77, overlap
11129.4, CH6.01, dt (9.8, 2.0)131.7, CH5.45, br d (9.7)131.8, CH5.44, dt (9.6, 2.0)
12132.2, CH5.58, ddd (9.8, 4.3, 2.0)132.6, CH5.58, br d (9.7)131.9, CH5.56, ddd (9.6, 4.4, 2.0)
1336.1, CH1.35, overlap36.7, CH2.15, q (6.1)36.3, CH2.14, m
1416.6, CH30.88, d (7.1)16.5, CH30.90, overlap16.1, CH30.90, d (7.0)
1522.3, CH30.83, overlap22.6, CH30.90, overlap22.5, CH30.88, d (6.4)
1619.2, CH30.91, d (6.4)176.9, C a 66.3, CH23.20, m
1-COOH 12.09, br s 12.02, br s
9-OH 4.56, br s
a Detected by HMBC data. b Detected by HSQC data.
Table 2. 1H and 13C NMR data of compounds 46 in DMSO-d6.
Table 2. 1H and 13C NMR data of compounds 46 in DMSO-d6.
No.456
δC, TypeδH (J in Hz)δC, TypeδH (J in Hz)δC, TypeδH (J in Hz)
1167.6, C 167.7, C 167.8, C a
2120.6, CH5.80, d (15.3)120.4, CH5.77, d (15.2)120.7, CH5.79, d (15.3)
3144.2, CH7.13, dd (15.3, 10.8)144.4, CH7.14, dd (15.2, 11.1)144.0, CH7.11, dd (15.3, 11.0)
4128.8, CH6.23, dd (15.1, 10.8)129.2, CH6.29 dd (15.3, 11.1)129.3, CH6.31, dd (15.3, 11.0)
5144.9, CH6.11, dd (15.1, 9.3)148.9, CH5.95, overlap148.9, CH6.00, dd (15.3, 9.4)
643.6, CH2.52, ddd (10.9, 9.3, 2.3)49.4, CH2.53, m49.5, CH2.52, m
749.4, CH1.39, dd (10.9, 7.5)43.6, CH1.19, m43.1, CH1.29, overlap
834.5, CH1.48, overlap34.6, CH1.41, overlap39.2, CH1.57, dd (12.3, 2.9)
944.7, CH21.70, m
0.89, m
48.7, CH21.41, overlap
0.98, m
39.5, CH21.29, overlap
0.73, q (12.3)
1036.3, CH1.48, overlap68.0, C 36.1, CH1.71, m
1144.0, CH22.14, ddd (12.1, 3.8, 1.8)
1.59, m
41.9, CH21.62, overlap
1.41, overlap
32.4, CH2α 1.15, overlap
β 1.52, m
12138.8, C 37.6, CH1.62, overlap42.2, CH1.15, overlap
13124.2, CH5.31, d (2.0)75.2, CH3.33, m65.5, CH3.66, d (6.0)
1468.7, CH3.59, m124.1, CH5.95, overlap127.1, CH5.74, dt (6.0, 1.5)
1536.2, CH1.48, overlap139.1, C 136.1, C
1615.6, CH30.90, d (6.8)22.0, CH31.58, s21.9, CH31.52, s
1720.4, CH30.92, d (6.3)21.5, CH30.81, d (6.6)22.1, CH30.88, d (5.9)
1822.1, CH30.87, d (6.5)31.5, CH31.08, s68.7, CH23.82, d (6.4)
13-OCH3 55.8, CH33.22, s
19 170.4, C
20 20.7, CH32.00, s
1-COOH 12.12, br s
a Detected by HMBC correlations.
Table 3. 1H and 13C NMR data of compounds 7 and 8 in DMSO-d6.
Table 3. 1H and 13C NMR data of compounds 7 and 8 in DMSO-d6.
No.78
δC, TypeδH (J in Hz)δC, TypeδH (J in Hz)
1168.8, C a 168.2, C
2123.9, CH5.82, d (15.4)121.2, CH5.80, d (15.3)
3141.8, CH7.01, dd (15.4, 11.1)144.5, CH7.12, dd (15.3, 11.0)
4129.6, CH6.22, td (11.1, 5.2)129.6, CH6.28, dd (15.3, 11.0)
5146.6, CH5.78, dd (11.1, 5.2)149.0, CH5.94, dd (15.3, 9.2)
649.5, CH2.53, m49.6, CH2.57, t (9.2)
740.0, CH1.57, overlap48.7, CH0.99, m
842.1, CH1.23, overlap39.2, CH1.37, overlap
939.2, CH21.23, overlap
0.63, dd (12.2, 5.6)
40.0, CH21.61, d (12.5)
0.70, q (12.5)
1039.5, CH1.46, m39.2, CH1.37, overlap
1132.8, CH21.57, overlap
1.07, m
32.9, CH2α 2.17, d (12.3)
β 0.57, q (12.3)
1244.3, CH1.23, overlap43.8, CH1.10, m
1375.3, CH3.37, d (6.1)80.3, CH3.32, d (9.4)
14123.9, CH5.91, d (6.1)126.3, CH5.64, m
15139.4, C 134.7, C
1622.0, CH31.58, s21.9, CH31.55, s
1722.0, CH30.87, d (6.5)22.9, CH30.87 d (6.5)
1866.6, CH23.18, d (6.1)66.9, CH23.19, d (6.2)
13-OCH355.8, CH33.22, s55.7, CH33.26, s
18-OH 4.35, br s
a Detected by HMBC correlations.
Table 4. Antibacterial activities of active compounds 5 and 810 (MIC, μg/mL) a.
Table 4. Antibacterial activities of active compounds 5 and 810 (MIC, μg/mL) a.
E. tardaE. coliV. parahaemolyticusV. vulnificus
5--16-
8648--
9--64-
1016---
Chloramphenicol b2112
a (-) = MIC > 64 μg/mL. b Chloramphenicol as positive control.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hu, X.-Y.; Li, X.-M.; Wang, B.-G.; Meng, L.-H. Uncommon Polyketides from Penicillium steckii AS-324, a Marine Endozoic Fungus Isolated from Deep-Sea Coral in the Magellan Seamount. Int. J. Mol. Sci. 2022, 23, 6332. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23116332

AMA Style

Hu X-Y, Li X-M, Wang B-G, Meng L-H. Uncommon Polyketides from Penicillium steckii AS-324, a Marine Endozoic Fungus Isolated from Deep-Sea Coral in the Magellan Seamount. International Journal of Molecular Sciences. 2022; 23(11):6332. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23116332

Chicago/Turabian Style

Hu, Xue-Yi, Xiao-Ming Li, Bin-Gui Wang, and Ling-Hong Meng. 2022. "Uncommon Polyketides from Penicillium steckii AS-324, a Marine Endozoic Fungus Isolated from Deep-Sea Coral in the Magellan Seamount" International Journal of Molecular Sciences 23, no. 11: 6332. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23116332

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop